A Study Of Optimizing Detection Of Primary Aldosteronism

Overview

About this study

The purpose of this study is to use surveys and interviews, to identify multilevel barriers and facilitators to PA screening among clinicians, patients, and healthcare leaders and identify potential strategies to address them.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients (≥18 years) with documented hypertension
Clinicians treating hypertensive patients
Administrative or clinical leaders (e.g., department heads, clinic administrators) with roles relevant to PA screening

Exclusion Criteria:

Patients who do not provide research authorization to review their medical records for general research studies in accordance with Minnesota Status 144.335.
Patients under 18 years of age.
Inability to provide informed consent
Non-English speakers

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/03/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Juan Brito Campana, M.B.B.S.	Contact us for the latest status

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Juan Brito Campana, M.B.B.S.

Contact us for the latest status

More information

Publications

Publications are currently not available

Clinical Trials